Assessment of Medication Adherence in Ccu Admitted Patients (NCT07504406) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Assessment of Medication Adherence in Ccu Admitted Patients
Iraq250 participantsStarted 2026-03-01
Plain-language summary
This study aims to assess medication adherence and the appropriateness of prescribed medications among patients admitted to the Coronary Care Unit (CCU). The study will use the Medication Appropriateness Index (MAI) to evaluate the suitability of prescribed medications and the Beliefs about Medicines Questionnaire (BMQ) to assess patients' beliefs and perceptions regarding their medications. Understanding medication adherence and related beliefs may help identify factors associated with inappropriate medication use and non-adherence in hospitalized cardiac patients. The findings of this study may contribute to improving medication management and patient care in the CCU setting.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients aged 18 years or older
* Diagnosed with atrial fibrillation or heart failure
* Admitted to the coronary care unit
* Clinically stable at the time of interview
* Able to provide informed consent
Exclusion Criteria:
* Significant cognitive impairment
* Communication difficulties preventing interview
* Diagnosed psychiatric disorder interfering with participation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Medication adherence (BMQ)
Timeframe: During CCU admission after clinical stabilization (assessed up to 5 days)
2
Medication appropriateness measured by Medication Appropriateness Index (MAI)
Timeframe: During CCU admission after clinical stabilization (assessed up to 5 days)